INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,913,750 | +239.1% | 155,000 | +183.4% | 0.04% | +214.3% |
| Q2 2023 | $1,154,170 | +459.4% | 54,700 | +352.1% | 0.01% | +600.0% |
| Q1 2023 | $206,305 | -85.0% | 12,100 | -82.4% | 0.00% | -85.7% |
| Q4 2022 | $1,376,622 | +9.3% | 68,900 | +17.8% | 0.01% | 0.0% |
| Q3 2022 | $1,260,000 | +1066.7% | 58,500 | +963.6% | 0.01% | +1300.0% |
| Q2 2022 | $108,000 | +191.9% | 5,500 | +243.8% | 0.00% | – |
| Q1 2022 | $37,000 | -14.0% | 1,600 | 0.0% | 0.00% | – |
| Q4 2021 | $43,000 | -49.4% | 1,600 | -36.0% | 0.00% | -100.0% |
| Q1 2021 | $85,000 | -88.2% | 2,500 | -88.4% | 0.00% | -80.0% |
| Q4 2020 | $719,000 | -68.5% | 21,600 | -77.4% | 0.01% | -81.5% |
| Q4 2019 | $2,280,000 | +159.1% | 95,504 | +91.4% | 0.03% | +145.5% |
| Q3 2019 | $880,000 | +224.7% | 49,900 | +370.8% | 0.01% | +266.7% |
| Q2 2019 | $271,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |